These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35392299)

  • 1. Higher Risk, Higher Reward? Self-Reported Effects of Real-World Cannabis Use in Parkinson's Disease.
    Holden SK; Domen CH; Sillau S; Liu Y; Leehey MA
    Mov Disord Clin Pract; 2022 Apr; 9(3):340-350. PubMed ID: 35392299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol and Tetrahydrocannabinol Use in Parkinson's Disease: An Observational Pilot Study.
    Sousa A; DiFrancisco-Donoghue J
    Cureus; 2023 Jul; 15(7):e42391. PubMed ID: 37621812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis in Parkinson's Disease: The Patients' View.
    Yenilmez F; Fründt O; Hidding U; Buhmann C
    J Parkinsons Dis; 2021; 11(1):309-321. PubMed ID: 33216043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.
    Bonomo Y; Norman A; Collins L; O'Neill H; Galettis P; Trinca J; Strauss N; Martin J; Castle D
    Pain Ther; 2022 Mar; 11(1):171-189. PubMed ID: 34921662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
    Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
    Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Front Psychiatry; 2020; 11():613243. PubMed ID: 33408657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial.
    Solowij N; Broyd SJ; Beale C; Prick JA; Greenwood LM; van Hell H; Suo C; Galettis P; Pai N; Fu S; Croft RJ; Martin JH; Yücel M
    Cannabis Cannabinoid Res; 2018; 3(1):21-34. PubMed ID: 29607408
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase Ib, Double Blind, Randomized Study of Cannabis Oil for Pain in Parkinson's Disease.
    Di Luca DG; Gilmour GS; Fearon C; Swinkin E; Freitas E; Kuhlman G; Fox SH; Mestre T
    Mov Disord Clin Pract; 2023 Jul; 10(7):1114-1119. PubMed ID: 37476317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid Profiles in Medical Cannabis Users: Effects of Age, Gender, Symptoms, and Duration of Use.
    Kalaba M; Ware MA
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):840-851. PubMed ID: 33999649
    [No Abstract]   [Full Text] [Related]  

  • 15. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
    McFadden BR; Malone T
    Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
    Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
    Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
    J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.